Cart is empty The present variants of cancer immunotherapy such as immune checkpoint blockades only benefit a small subset of patients due to its immunosuppressive tumor microenvironment. The capacity to vaccinate tumors and reduce immunosuppression in the microenvironment is a significant method to improve cancer immunotherapy.
Leave A Comment